NCT02690948 2019-03-08Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin CancerStanford UniversityPhase 1/2 Completed16 enrolled 15 charts
NCT01154452 2018-08-15Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic SarcomaNational Cancer Institute (NCI)Phase 1/2 Completed78 enrolled 11 charts
NCT01174264 2017-05-19Evaluation of Food Effect on Pharmacokinetics of VismodegibNational Cancer Institute (NCI)Phase 1/2 Completed63 enrolled 21 charts